← back to search

Weining Zhen

Amgen (United States) · US
Area of research
Otorhinolaryngology · Radiation
Research interest
Research focused on Larynx and Head and neck, with related work in Head and neck cancer, Lung cancer, Occult. Notable publications include 'Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology', 'NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018', and 'NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022'.
h-index
citations
3,564
works
10
NIH funding
primary concept
email

Recent publications

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025
Journal of the National Comprehensive Cancer Network 2025cited by 118position: middledoi
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022
Journal of the National Comprehensive Cancer Network 2022cited by 524position: middledoi
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network 2020cited by 1,358position: middledoi
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
Journal of the National Comprehensive Cancer Network 2018cited by 626position: middledoi
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
Journal of the National Comprehensive Cancer Network 2017cited by 377position: middledoi
A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT
Radiation Oncology 2017cited by 20position: middledoi
A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma
Annals of Surgery 2016cited by 291position: middledoi
Multi‐institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non–small cell lung tumors
Cancer 2016cited by 99position: middledoi
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics 2016cited by 90position: middledoi
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis
International Journal of Radiation Oncology*Biology*Physics 2016cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ronald C. McGarry · University of Kentucky2 papers (2016–2016)Adrian S. Iskhanian · University of Miami2 papers (2016–2016)Percy Lee · University of California, Los Angeles2 papers (2016–2016)Roy H. Decker · Yale Cancer Center2 papers (2016–2016)Matthew M. Harkenrider · Loyola University Chicago2 papers (2016–2016)Christopher L. Hallemeier · Mayo Clinic in Arizona2 papers (2016–2016)Kyle Wang · University of North Carolina at Chapel Hill2 papers (2016–2016)Charles B. Simone · Novartis (United States)2 papers (2016–2016)Salma K. Jabbour · Rutgers, The State University of New Jersey2 papers (2016–2016)Valerie Shostrom · University of Tennessee at Knoxville2 papers (2016–2016)Chi Lin · University of Colorado Denver2 papers (2016–2017)Vivek Verma · AstraZeneca (Canada)2 papers (2016–2016)Steve Braunstein · Pediatric Brain Tumor Foundation2 papers (2016–2016) · 2 papers (2016–2016)Albert Attia · Wake Forest University2 papers (2016–2016)Christina Zhou · University of Illinois Chicago1 papers (2017–2017)Andrew O. Wahl · Medical College of Wisconsin1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017)Maria B. Majella Doyle · Washington University in St. Louis1 papers (2016–2016)